Abstract:Tumor cells possess complex immune evasion mechanisms to evade immune system attacks, primarily through metabolic reprogramming, which significantly alters the tumor microenvironment (TME) to modulate immune cell functions. When a tumor is sufficiently immunogenic, it can activate cytotoxic T-cells to target and destroy it. However, tumors adapt by manipulating their metabolic pathways, particularly glucose, amino acid, and lipid metabolism, to create an immunosuppressive TME that promotes immune escape. These metabolic alterations impact the function and differentiation of non-tumor cells within the TME, such as inhibiting effector T-cell activity while expanding regulatory T-cells and myeloid-derived suppressor cells. Additionally, these changes lead to an imbalance in cytokine and chemokine secretion, further enhancing the immunosuppressive landscape. Emerging research is increasingly focusing on the regulatory roles of non-tumor cells within the TME, evaluating how their reprogrammed glucose, amino acid, and lipid metabolism influence their functional changes and ultimately aid in tumor immune evasion. Despite our incomplete understanding of the intricate metabolic interactions between tumor and non-tumor cells, the connection between these elements presents significant challenges for cancer immunotherapy. This review highlights the impact of altered glucose, amino acid, and lipid metabolism in the TME on the metabolism and function of non-tumor cells, providing new insights that could facilitate the development of novel cancer immunotherapies.

Metabolic interventions: A new insight into the cancer immunotherapy

Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications

Targeting T Cell Metabolism in the Tumor Microenvironment: an Anti-Cancer Therapeutic Strategy

Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy

The cancer metabolic reprogramming and immune response

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment

Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy

Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy

Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer

Nanomaterial-enabled metabolic reprogramming strategies for boosting antitumor immunity

Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy

The Role of Tumor Metabolic Reprogramming in Tumor Immunity

Metabolic Crosstalk in the Tumor Microenvironment Regulates Antitumor Immunosuppression and Immunotherapy Resisitance.

Targeting metabolism of breast cancer and its implications in T cell immunotherapy

Cancer Metabolism and Intervention Therapy

Metabolic reprogramming of macrophages in cancer therapy

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy.